131 related articles for article (PubMed ID: 15285315)
21. Tenascin expression in normal, hyperplastic, and neoplastic endometrium.
Sedele M; Karaveli S; Peştereli HE; Simşek T; Elpek G; Uner M; Sargin CF
Int J Gynecol Pathol; 2002 Apr; 21(2):161-6. PubMed ID: 11917226
[TBL] [Abstract][Full Text] [Related]
22. [Relationships between the molecular biomarkers and the clinicopathologic features and prognosis in endometrial carcinoma].
Yao YY; Xu WZ; Wang Y; Shen DH; Wang JL; Wei LH
Beijing Da Xue Xue Bao Yi Xue Ban; 2011 Oct; 43(5):743-8. PubMed ID: 22008688
[TBL] [Abstract][Full Text] [Related]
23. Expression of pS2 protein in endometrial carcinomas: correlation with clinicopathologic features and sex steroid receptor status.
Koshiyama M; Yoshida M; Konishi M; Takemura M; Yura Y; Matsushita K; Hayashi M; Tauchi K
Int J Cancer; 1997 Jun; 74(3):237-44. PubMed ID: 9221798
[TBL] [Abstract][Full Text] [Related]
24. [Expression of p53, Ki-67, bcl-2, c-erb-2, estrogen, and progesterone receptors in endometrial cancer].
Pilka R; Mícková I; Lubuský M; Dusková M; Rícánková M; Kudela M
Ceska Gynekol; 2008 Jul; 73(4):222-7. PubMed ID: 18711961
[TBL] [Abstract][Full Text] [Related]
25. Could E-Cadherin and CD10 Expression be Used to Differentiate Between Atypical Endometrial Hyperplasia and Endometrial Carcinoma?
Youssef MY; Mohamed MA
Int J Gynecol Pathol; 2019 Mar; 38(2):128-137. PubMed ID: 30726192
[TBL] [Abstract][Full Text] [Related]
26. Enhanced CD24 expression in endometrial carcinoma and its expression pattern in normal and hyperplastic endometrium.
Kim KH; Choi JS; Kim JM; Choi YL; Shin YK; Lee HC; Seong IO; Kim BK; Chae SW; Kim SH
Histol Histopathol; 2009 Mar; 24(3):309-16. PubMed ID: 19130400
[TBL] [Abstract][Full Text] [Related]
27. Apoptosis-related proteins and steroid hormone receptors in normal, hyperplastic, and neoplastic endometrium.
Bozdoğan O; Atasoy P; Erekul S; Bozdoğan N; Bayram M
Int J Gynecol Pathol; 2002 Oct; 21(4):375-82. PubMed ID: 12352186
[TBL] [Abstract][Full Text] [Related]
28. Patterns of episialin/MUC1 expression in endometrial carcinomas and prognostic relevance.
Sivridis E; Giatromanolaki A; Koukourakis MI; Georgiou L; Anastasiadis P
Histopathology; 2002 Jan; 40(1):92-100. PubMed ID: 11903603
[TBL] [Abstract][Full Text] [Related]
29. Expression of hPEBP4 negatively correlates with estrogen and progesterone receptors in endometrial carcinoma.
Guo T; Li B; Gu C
J BUON; 2013; 18(2):465-70. PubMed ID: 23818363
[TBL] [Abstract][Full Text] [Related]
30. Supervised clustering of immunohistochemical markers to distinguish atypical endometrial hyperplasia from grade 1 endometrial cancer.
Laas E; Ballester M; Cortez A; Gonin J; Daraï E; Graesslin O
Gynecol Oncol; 2014 May; 133(2):205-10. PubMed ID: 24556060
[TBL] [Abstract][Full Text] [Related]
31. IMMUNOHISTOCHEMISTRY IN ENDOMETRIAL HYPERPLASIA AND ENDOMETRIAL ADENOCARCINOMA.
Socolov D; Socolov R; Lupascu IA; Rugina V; Gabia O; Garauleanu DM; Carauleanu A
Rev Med Chir Soc Med Nat Iasi; 2016; 120(2):355-62. PubMed ID: 27483717
[TBL] [Abstract][Full Text] [Related]
32. Tumor stiffness measured by 3D magnetic resonance elastography can help predict the aggressiveness of endometrial carcinoma: preliminary findings.
Zhang L; Long X; Nijiati M; Zhang T; Li M; Deng Y; Kuang S; Xiao Y; Zhu J; He B; Chen J; Rossman P; Glaser KJ; Venkatesh SK; Ehman RL; Wang J
Cancer Imaging; 2021 Aug; 21(1):50. PubMed ID: 34454623
[TBL] [Abstract][Full Text] [Related]
33. Malignant transformation of the human endometrium is associated with overexpression of lactoferrin messenger RNA and protein.
Walmer DK; Padin CJ; Wrona MA; Healy BE; Bentley RC; Tsao MS; Kohler MF; McLachlan JA; Gray KD
Cancer Res; 1995 Mar; 55(5):1168-75. PubMed ID: 7867003
[TBL] [Abstract][Full Text] [Related]
34. Immunohistochemical study of apoptosis-related Bcl-2 protein and its correlation with proliferation indices (Ki67, PCNA), tumor suppressor genes (p53, pRb), the oncogene c-erbB-2, sex steroid hormone receptors and other clinicopathological features, in normal, hyperplastic and neoplastic endometrium.
Mitselou A; Ioachim E; Kitsou E; Vougiouklakis T; Zagorianakou N; Makrydimas G; Stefanaki S; Agnantis NJ
In Vivo; 2003; 17(5):469-77. PubMed ID: 14598611
[TBL] [Abstract][Full Text] [Related]
35. The clinical significance of tumor-associated antigen RCAS1 expression in the normal, hyperplastic, and malignant uterine endometrium.
Sonoda K; Kaku T; Hirakawa T; Kobayashi H; Amada S; Sakai K; Nakashima M; Watanabe T; Nakano H
Gynecol Oncol; 2000 Dec; 79(3):424-9. PubMed ID: 11104614
[TBL] [Abstract][Full Text] [Related]
36. DNA ploidy, cell proliferation and steroid hormone receptors in endometrial hyperplasia and early adenocarcinoma.
Punnonen R; Mattila J; Kuoppala T; Koivula T
J Cancer Res Clin Oncol; 1993; 119(7):426-9. PubMed ID: 8491764
[TBL] [Abstract][Full Text] [Related]
37. The expression analysis of the estrogen and progesterone receptors in endometrial carcinomas.
Olech-Fudali E; Chibowski D; Skomra D; Walczyna B
Ann Univ Mariae Curie Sklodowska Med; 2001; 56():319-25. PubMed ID: 11977333
[TBL] [Abstract][Full Text] [Related]
38. Immunohistochemical evaluation of cathepsin D in normal, hyperplastic and malignant endometrium: correlation with hormone receptor status c-erbB-2, p53, Rb proteins and proliferation associated indices.
Ioachim E; Kitsiou E; Charalabopoulos K; Mitselou A; Zagorianakou N; Makrydimas G; Tzioras S; Salmas M
Int J Gynecol Cancer; 2003; 13(3):344-51. PubMed ID: 12801267
[TBL] [Abstract][Full Text] [Related]
39. Clear cell carcinoma of the endometrium is characterized by a distinctive profile of p53, Ki-67, estrogen, and progesterone receptor expression.
Lax SF; Pizer ES; Ronnett BM; Kurman RJ
Hum Pathol; 1998 Jun; 29(6):551-8. PubMed ID: 9635673
[TBL] [Abstract][Full Text] [Related]
40. STAR and AKR1B10 are down-regulated in high-grade endometrial cancer.
Sinreih M; Štupar S; Čemažar L; Verdenik I; Frković Grazio S; Smrkolj Š; Rižner TL
J Steroid Biochem Mol Biol; 2017 Jul; 171():43-53. PubMed ID: 28232277
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
